Nancy U. Lin, MD
Dr. Nancy Lin, the Director of the Metastatic Breast Cancer Program at Dana-Farber Cancer Institute, joins Lisa Laudico and co-host, Chawnte Randall, for a conversation on the issues with brain mets research for MBC patients, some of the latest research and trials for brain mets and MBC, Dr. Lin's reflections on tele-health and how Covid 19 has impacted her.
SOCIAL/HASHTAGS/GUEST INFO
@danafarber
@nlinmd
Nancy U Lin, MD profile at Dana-Farber Cancer Institute
#brainmets
#clinicaltrials
MENTIONED IN THIS EPISODE
Dana Farber Brain MRI Clinical Trial
Dana Farber Her2+ Brain Mets Trial
Mass General Study: How Brain Metastases May Be Shaped by the Genetic Alterations and the Microenvironment In the Brain
Brain Metastasis Program Helps Forge New Era at Mass General Cancer Center
Workshop on Product Development for CNS Metastases
Clinical Trial Eligibility Expansion
Study defines clinical trials likely to exclude patients with brain metastases
TELEHEALTH/TELEMEDICINE
Telemedicine in Cancer Care: So Far and Yet So Close
Telehealth Advocates Launch Task Force to Lobby for Permanent Policy Changes
Tech Companies are Transforming People’s Bedrooms into ‘Virtual Hospitals’: Will it Last Post COVID?
CANCER INSTITUTES AND BRAIN METASTASES
MD Anderson: What are Brain Metastases?
Dana Farber Cancer Institute: Brain Metastases Treatment Approach
Duke Cancer Institute Center for Brain and Spine Metastasis
John Hopkins Medicine: Neurology and Neurosurgery
Brain Metastases Care at Mayo Clinic
BRAIN METS, CLINICAL TRIALS
National Cancer Institute: Clinical Trials to Treat Adult Metastatic Brain Tumors
MD Anderson: Brain Metastases Symptoms
National Library of Medicine: Clinical Trials
